Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc. buy tbackenh

Start price
€320.85
08.06.21 / 80%
Target price
€330.00
08.06.22
Performance (%)
1.95%
Price
€327.10
18.06.21
Summary
This prediction is currently active. With a performance of 1.95%, the BUY prediction by tbackenh for Biogen Inc. is trending in the right direction. This prediction currently runs until 08.06.22. The prediction end date can be changed by tbackenh at any time. tbackenh has 80% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Biogen Inc. -0.107%
S&P 500 -2.220%

According to tbackenh what are the pros and cons of Biogen Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
Future proof or reliable business model
Cons

Comments by tbackenh for this prediction

In the thread Biogen Inc. diskutieren
Prediction Buy
Perf. (%) 1.95%
Target price 330.000
Change
Ends at 08.06.22

Zulassung der US-amerikanischen Food and Drug Administration für die Alzheimer-Behandlung ADUHELM (Aducanumab) ist genehmigt. Dies sollte frischen Wind bringen. Nach dem > 30% Kurssprung gestern kann allerdings auch zunächst das GAP nach unten geschlossen werden. Langfristiges BUY!